Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1

Conditions

Signs and Symptoms 1Sexuality 1Sexual Dysfunction, Physiological 1Hematologic Neoplasms 1

Interventions

Cytarabine 898Cyclophosphamide 893fludarabine 517venetoclax 475fludarabine phosphate 464Azacitidine 451Rituximab 418Methotrexate 414Etoposide 319Filgrastim 299Busulfan 295Dexamethasone 284Vincristine 280Daunorubicin 279Peripheral Blood Stem Cell Transplantation 257Whole-Body Irradiation 240Mycophenolic Acid 231Decitabine 228Granulocyte Colony-Stimulating Factor 225Tacrolimus 219Idarubicin 203Melphalan 201Imatinib Mesylate 195Cyclosporine 182Doxorubicin 176Radiotherapy 169Prednisone 161Mitoxantrone 160Lenalidomide 159Mercaptopurine 154

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Sexual Health × Other hematologic neoplasm × Clear all
NCT05222282 2023-09-28

Sexual Health in Patients With Hematologic Malignancies

Rigshospitalet, Denmark

Phase NA Unknown
110 enrolled
OtherOther hematologic neoplasm

Sexual Dysfunction, Physiological, Signs and Symptoms, Hematologic Neoplasms, Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon âš¡